145 related articles for article (PubMed ID: 28453560)
1. Caspase polymorphisms and prognosis of hepatocellular carcinoma.
Zhang S; Xiao Q; Shi Z; Yu G; Ma XP; Chen H; Zhang P; Shen S; Sai-Yin HG; Chen TY; Lu PX; Wang NJ; Ren W; Huang P; Xie J; Conran C; Zheng SL; Yu L; Xu J; Jiang DK
PLoS One; 2017; 12(4):e0176802. PubMed ID: 28453560
[TBL] [Abstract][Full Text] [Related]
2. Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea.
Shin SP; Kim NK; Kim JH; Lee JH; Kim JO; Cho SH; Park H; Kim MN; Rim KS; Hwang SG
World J Gastroenterol; 2015 Dec; 21(46):13064-72. PubMed ID: 26672513
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer.
Yoo SS; Choi JE; Lee WK; Choi YY; Kam S; Kim MJ; Jeon HS; Lee EB; Kim DS; Lee MH; Kim IS; Jheon S; Park JY
J Clin Oncol; 2009 Dec; 27(34):5823-9. PubMed ID: 19826114
[TBL] [Abstract][Full Text] [Related]
4. Associations between single nucleotide polymorphisms in RYBP and the prognosis of hepatocellular carcinoma in a Chinese population.
Zhu X; Wang Z; Qiu X; Tan C; Yu H; Bei C; Qin L; Ren Y; Tan S
Carcinogenesis; 2017 May; 38(5):532-540. PubMed ID: 28369212
[TBL] [Abstract][Full Text] [Related]
5. CASP 3 genetic polymorphisms and risk of Hepatocellular carcinoma: a case-control study in a Chinese population.
Deng B; Liu F; Luo L; Wei Y; Li B; Yang H
Tumour Biol; 2016 Jul; 37(7):8985-91. PubMed ID: 26758428
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of Notch receptors in postsurgical patients with hepatitis B virus-related hepatocellular carcinoma.
Yu T; Han C; Zhu G; Liao X; Qin W; Yang C; Liu Z; Su H; Liu X; Yu L; Liu Z; Lu S; Chen Z; Liang Y; Huang J; Qin X; Gui Y; Li J; Peng T
Cancer Med; 2017 Jul; 6(7):1587-1600. PubMed ID: 28568708
[TBL] [Abstract][Full Text] [Related]
7. Association of single nucleotide polymorphisms in VDR and DBP genes with HBV-related hepatocellular carcinoma risk in a Chinese population.
Peng Q; Yang S; Lao X; Li R; Chen Z; Wang J; Qin X; Li S
PLoS One; 2014; 9(12):e116026. PubMed ID: 25541958
[TBL] [Abstract][Full Text] [Related]
8. The MTHFR polymorphism affect the susceptibility of HCC and the prognosis of HCC liver transplantation.
Wang C; Xie H; Lu D; Ling Q; Jin P; Li H; Zhuang R; Xu X; Zheng S
Clin Transl Oncol; 2018 Apr; 20(4):448-456. PubMed ID: 29185200
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
[TBL] [Abstract][Full Text] [Related]
10. Role of cytokine gene polymorphisms on prognosis in hepatocellular carcinoma after radical surgery resection.
Pan D; Zeng X; Yu H; Yang Y; Bei C; Bai H; Qiu X
Gene; 2014 Jul; 544(1):32-40. PubMed ID: 24768182
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants of cell cycle pathway genes predict disease-free survival of hepatocellular carcinoma.
Liu S; Yang TB; Nan YL; Li AH; Pan DX; Xu Y; Li S; Li T; Zeng XY; Qiu XQ
Cancer Med; 2017 Jul; 6(7):1512-1522. PubMed ID: 28639733
[TBL] [Abstract][Full Text] [Related]
12. Association of Functional Genetic Variants of HOTAIR with Hepatocellular Carcinoma (HCC) Susceptibility in a Chinese Population.
Li H; Tang XM; Liu Y; Li W; Chen Q; Pan Y
Cell Physiol Biochem; 2017; 44(2):447-454. PubMed ID: 29141248
[TBL] [Abstract][Full Text] [Related]
13. Fas -670 A/G polymorphism predicts prognosis of hepatocellular carcinoma after curative resection in Chinese Han population.
Guo XY; Xia YL; Li ZY; Li R; Fan Y; Yao WM; Liu F
Hepatobiliary Pancreat Dis Int; 2022 Feb; 21(1):33-40. PubMed ID: 34366198
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting the recurrence and survival of hepatocellular carcinoma after hepatectomy: a retrospective study of 601 Chinese patients.
Zhang TT; Zhao XQ; Liu Z; Mao ZY; Bai L
Clin Transl Oncol; 2016 Aug; 18(8):831-40. PubMed ID: 26577107
[TBL] [Abstract][Full Text] [Related]
15. Association of CTLA-4, TNF alpha and IL 10 polymorphisms with susceptibility to hepatocellular carcinoma.
Wang JJ; Wang ZB; Tan TC
Scand J Immunol; 2019 Dec; 90(6):e12819. PubMed ID: 31448426
[TBL] [Abstract][Full Text] [Related]
16. Functional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients.
Yuan P; Wang S; Zhou F; Wan S; Yang Y; Huang X; Zhang Z; Zhu Y; Zhang H; Xing J
Cancer Sci; 2014 Jul; 105(7):825-32. PubMed ID: 24754267
[TBL] [Abstract][Full Text] [Related]
17. MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma.
Ma XP; Yu G; Chen X; Xiao Q; Shi Z; Zhang LY; Chen H; Zhang P; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu H; Conran C; Sun J; Zheng SL; Xu J; Yu L; Jiang DK
Tumour Biol; 2016 Jul; 37(7):9931-42. PubMed ID: 26815502
[TBL] [Abstract][Full Text] [Related]
18. Recipient C7 rs9292795 genotype and the risk of hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.
Jiang Z; Jiang Q; Fang X; Wang P; Que W; Li H; Yu Y; Liu X; Wang C; Zhong L
BMC Cancer; 2021 May; 21(1):521. PubMed ID: 33964921
[TBL] [Abstract][Full Text] [Related]
19. Relationship Between CASP9 and CASP10 Gene Polymorphisms and Cancer Susceptibility: Evidence from an Updated Meta-analysis.
Sargazi S; Abghari AZ; Sarani H; Sheervalilou R; Mirinejad S; Saravani R; Eskandari E
Appl Biochem Biotechnol; 2021 Dec; 193(12):4172-4196. PubMed ID: 34463927
[TBL] [Abstract][Full Text] [Related]
20. MDR1 gene polymorphism correlated with pathological characteristics and prognosis in patients with primary hepatocellular carcinoma receiving interventional therapy.
Hu W; Huang S; Dong L; Yu C; Li C; Zhang J
Anticancer Drugs; 2019 Mar; 30(3):233-240. PubMed ID: 30779721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
